Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Class A common stock, $0.001 par value per share
Shares outstanding
71,297,491
Total 13F shares
51,298,718
Share change
+9,949,719
Total reported value
$2,212,007,022
Put/Call ratio
237%
Price per share
$43.12
Number of holders
157
Value change
+$474,171,827
Number of buys
119
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 92337R101?
CUSIP 92337R101 identifies VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) as of Q1 2024

As of 31 Mar 2024, Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,298,718 shares. The largest 10 holders included Avoro Capital Advisors LLC, BlackRock Inc., COMMODORE CAPITAL LP, FMR LLC, Sofinnova Investments, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, VANGUARD GROUP INC, Eversept Partners, LP, and MORGAN STANLEY. This page lists 157 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.